CollPlant Biotechnologies (CLGN) Selling, General & Administrative (2017 - 2026)
CollPlant Biotechnologies' Selling, General & Administrative was $1.01 million in the quarter ended Jun 30, 2026, down 12.6% from $1.16 million a year earlier and down 15.2% from the prior quarter.
CollPlant Biotechnologies (CLGN) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, CollPlant Biotechnologies' Selling, General & Administrative was $4.47 million through Jun 30, 2026, down 15.6% year-over-year; for the year ended Dec 31, 2025, it came in at $4.83 million, down 14.1% from the prior year.
- Selling, General & Administrative has now declined for three consecutive years, though with a five-year compound annual growth rate of 0.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Selling, General & Administrative was $5.63 million in the year ended Dec 31, 2024 (-6.2%), $6 million in the year ended Dec 31, 2023 (-11.1%), $6.74 million in the year ended Dec 31, 2022 (+13.5%) and $5.94 million in the year ended Dec 31, 2021 (+27.2%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Selling, General & Administrative since the quarter ended Jun 30, 2020.
- Compared with a year earlier, Selling, General & Administrative has declined for eight straight quarters, with an average decline of 14.0% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was the quarter ended Dec 31, 2022 (growth of 47.8%); the worst was the quarter ended Dec 31, 2023 (a decline of 27.2%).
- Per Business Quant data, CLGN's Selling, General & Administrative in the three quarters before the quarter ended Jun 30, 2026 was $1.19 million (quarter ended Mar 30, 2026), $1.04 million (quarter ended Dec 31, 2025) and $1.23 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.28 Bn |
| 10 | CollPlant Biotechnologies | 4.98 Mn | -17.38 Mn | -456,000.00 | 1.01 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.42 Mn |
CollPlant Biotechnologies Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();